Healthcare Value Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $4.19M | Sell |
60,000
-15,000
| -20% | -$1.05M | 8.27% | 1 |
|
|
2021
Q2 | $5.17M | Hold |
75,000
| – | – | 10.29% | 1 |
|
|
2021
Q1 | $4.85M | Buy |
75,000
+25,000
| +50% | +$1.62M | 10.8% | 1 |
|
|
2020
Q4 | $2.91M | Hold |
50,000
| – | – | 9.81% | 4 |
|
|
2020
Q3 | $3.16M | Hold |
50,000
| – | – | 10.41% | 3 |
|
|
2020
Q2 | $3.85M | Hold |
50,000
| – | – | 9.82% | 2 |
|
|
2020
Q1 | $3.74M | Sell |
50,000
-20,000
| -29% | -$1.5M | 6.29% | 3 |
|
|
2019
Q4 | $4.55M | Hold |
70,000
| – | – | 13.39% | 2 |
|
|
2019
Q3 | $4.44M | Hold |
70,000
| – | – | 8.01% | 1 |
|
|
2019
Q2 | $4.73M | Buy |
70,000
+20,000
| +40% | +$1.35M | 8.87% | 2 |
|
|
2019
Q1 | $3.25M | Buy |
+50,000
| New | +$3.25M | 12.53% | 4 |
|
|
2018
Q4 | – | Sell |
-100,000
| Closed | -$7.72M | – | 10 |
|
|
2018
Q3 | $7.72M | Hold |
100,000
| – | – | 18.67% | 1 |
|
|
2018
Q2 | $7.08M | Hold |
100,000
| – | – | 20.08% | 1 |
|
|
2018
Q1 | $7.54M | Buy |
100,000
+25,000
| +33% | +$1.88M | 31.33% | 1 |
|
|
2017
Q4 | $5.37M | Hold |
75,000
| – | – | 16.34% | 2 |
|
|
2017
Q3 | $6.08M | Hold |
75,000
| – | – | 12.16% | 4 |
|
|
2017
Q2 | $5.31M | Hold |
75,000
| – | – | 9.54% | 4 |
|
|
2017
Q1 | $5.09M | Hold |
75,000
| – | – | 8.71% | 3 |
|
|
2016
Q4 | $5.37M | Buy |
75,000
+50,000
| +200% | +$3.58M | 5.75% | 6 |
|
|
2016
Q3 | $1.98M | Buy |
+25,000
| New | +$1.98M | 3.13% | 9 |
|